$13.73
00.00%
Pre-Market: Sep 20, 4:02 PM EDT
15 minutes delayed
Comments
Loading...
Y-mAbs Therapeutics (NASDAQ:YMAB) Stock, Earnings Estimates, EPS, And Revenue
Y-mAbs Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 11
EPS Estimate
$-0.150
Quarterly Revenue Estimate
$23.8M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$86.5M
Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Y-mAbs Therapeutics (YMAB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-12 | $-0.21 | $-0.13 | -61.5 % |
| Mar 2024 | 2024-05-07 | $-0.15 | $-0.14 | -7.14 % |
| Dec 2023 | 2024-02-29 | $-0.02 | $-0.20 | 90.0 % |
| Sep 2023 | 2023-11-13 | $-0.18 | $-0.19 | 5.26 % |
Y-mAbs Therapeutics (YMAB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-12 | $22.80M | $23.02M | -0.96 % |
| Mar 2024 | 2024-05-07 | $19.93M | $22.22M | -10.3 % |
| Dec 2023 | 2024-02-29 | $23.36M | $20.95M | 11.5 % |
| Sep 2023 | 2023-11-13 | $20.45M | $20.93M | -2.27 % |
FAQ
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?
The Actual EPS was $-0.21, which missed the estimate of $-0.13.
What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?
The Actual Revenue was $22.8M, which missed the estimate of $23M.
Browse earnings estimates, EPS, and revenue on all stocks.